nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicergoline—CYP2D6—Parkinson's disease	0.982	1	CbGaD
Nicergoline—Methysergide—HTR7—Parkinson's disease	0.00417	0.441	CrCbGaD
Nicergoline—Methysergide—HTR1A—Parkinson's disease	0.00319	0.338	CrCbGaD
Nicergoline—Methysergide—HTR2A—Parkinson's disease	0.0021	0.222	CrCbGaD
Nicergoline—CYP2D6—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.000289	0.0346	CbGpPWpGaD
Nicergoline—CYP2D6—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.000287	0.0343	CbGpPWpGaD
Nicergoline—ADRA1A—Monoamine GPCRs—HTR1A—Parkinson's disease	0.000223	0.0267	CbGpPWpGaD
Nicergoline—ADRA1A—Monoamine GPCRs—DRD1—Parkinson's disease	0.000215	0.0257	CbGpPWpGaD
Nicergoline—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000212	0.0254	CbGpPWpGaD
Nicergoline—ADRA1A—Monoamine GPCRs—DRD3—Parkinson's disease	0.000208	0.0249	CbGpPWpGaD
Nicergoline—ADRA1A—Monoamine GPCRs—HTR7—Parkinson's disease	0.000188	0.0225	CbGpPWpGaD
Nicergoline—ADRA1A—Monoamine GPCRs—DRD2—Parkinson's disease	0.000188	0.0225	CbGpPWpGaD
Nicergoline—ADRA1A—Amine ligand-binding receptors—HTR1A—Parkinson's disease	0.000187	0.0224	CbGpPWpGaD
Nicergoline—ADRA1A—Amine ligand-binding receptors—DRD1—Parkinson's disease	0.000181	0.0216	CbGpPWpGaD
Nicergoline—CYP2D6—Xenobiotics—CYP2E1—Parkinson's disease	0.000178	0.0213	CbGpPWpGaD
Nicergoline—ADRA1A—Amine ligand-binding receptors—DRD3—Parkinson's disease	0.000175	0.021	CbGpPWpGaD
Nicergoline—CYP2D6—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000171	0.0205	CbGpPWpGaD
Nicergoline—ADRA1A—Amine ligand-binding receptors—DRD2—Parkinson's disease	0.000158	0.019	CbGpPWpGaD
Nicergoline—ADRA1A—Amine ligand-binding receptors—HTR7—Parkinson's disease	0.000158	0.019	CbGpPWpGaD
Nicergoline—ADRA1A—Calcium Regulation in the Cardiac Cell—GRK6—Parkinson's disease	0.000151	0.0181	CbGpPWpGaD
Nicergoline—ADRA1A—Endothelin Pathways—EDN1—Parkinson's disease	0.000151	0.0181	CbGpPWpGaD
Nicergoline—ADRA1A—G alpha (q) signalling events—DGKQ—Parkinson's disease	0.000137	0.0165	CbGpPWpGaD
Nicergoline—ADRA1A—Monoamine GPCRs—HTR2A—Parkinson's disease	0.000132	0.0158	CbGpPWpGaD
Nicergoline—ADRA1A—AMPK Signaling—INSR—Parkinson's disease	0.000131	0.0157	CbGpPWpGaD
Nicergoline—ADRA1A—Calcium Regulation in the Cardiac Cell—GRK5—Parkinson's disease	0.000125	0.015	CbGpPWpGaD
Nicergoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKQ—Parkinson's disease	0.000123	0.0147	CbGpPWpGaD
Nicergoline—ADRA1A—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.000111	0.0133	CbGpPWpGaD
Nicergoline—CYP2D6—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.000109	0.013	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.000106	0.0127	CbGpPWpGaD
Nicergoline—ADRA1A—G alpha (q) signalling events—GRK5—Parkinson's disease	0.000104	0.0125	CbGpPWpGaD
Nicergoline—CYP2D6—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.000101	0.0121	CbGpPWpGaD
Nicergoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—Parkinson's disease	9.31e-05	0.0112	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	9.1e-05	0.0109	CbGpPWpGaD
Nicergoline—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	8.8e-05	0.0105	CbGpPWpGaD
Nicergoline—CYP2D6—Melatonin metabolism and effects—APOE—Parkinson's disease	8.23e-05	0.00986	CbGpPWpGaD
Nicergoline—ADRA1A—G alpha (q) signalling events—GRM5—Parkinson's disease	7.53e-05	0.00902	CbGpPWpGaD
Nicergoline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	7.38e-05	0.00884	CbGpPWpGaD
Nicergoline—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	7.28e-05	0.00872	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—GPR37—Parkinson's disease	6.93e-05	0.0083	CbGpPWpGaD
Nicergoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	6.73e-05	0.00807	CbGpPWpGaD
Nicergoline—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	5.98e-05	0.00716	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	5.86e-05	0.00703	CbGpPWpGaD
Nicergoline—ADRA1A—G alpha (q) signalling events—TAC1—Parkinson's disease	5.47e-05	0.00655	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	5.36e-05	0.00643	CbGpPWpGaD
Nicergoline—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	5.24e-05	0.00628	CbGpPWpGaD
Nicergoline—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	5.17e-05	0.00619	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	4.95e-05	0.00593	CbGpPWpGaD
Nicergoline—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	4.92e-05	0.00589	CbGpPWpGaD
Nicergoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	4.89e-05	0.00586	CbGpPWpGaD
Nicergoline—ADRA1A—G alpha (q) signalling events—ADRBK1—Parkinson's disease	4.85e-05	0.00581	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—GRM4—Parkinson's disease	4.71e-05	0.00564	CbGpPWpGaD
Nicergoline—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	4.67e-05	0.0056	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—PENK—Parkinson's disease	4.47e-05	0.00535	CbGpPWpGaD
Nicergoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	4.34e-05	0.0052	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	4.29e-05	0.00514	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	4.24e-05	0.00508	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	4.15e-05	0.00497	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—PDYN—Parkinson's disease	4.08e-05	0.00489	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	4.02e-05	0.00481	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—DGKQ—Parkinson's disease	3.92e-05	0.00469	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—GRM5—Parkinson's disease	3.8e-05	0.00455	CbGpPWpGaD
Nicergoline—ADRA1A—G alpha (q) signalling events—EDN1—Parkinson's disease	3.76e-05	0.00451	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	3.68e-05	0.00441	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	3.63e-05	0.00435	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	3.63e-05	0.00435	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	3.62e-05	0.00434	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—DGKQ—Parkinson's disease	3.56e-05	0.00426	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—GPR37—Parkinson's disease	3.56e-05	0.00426	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	3.55e-05	0.00426	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	3.44e-05	0.00412	CbGpPWpGaD
Nicergoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	3.36e-05	0.00403	CbGpPWpGaD
Nicergoline—ADRA1A—G alpha (q) signalling events—HTR2A—Parkinson's disease	3.29e-05	0.00394	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—PPP1R1B—Parkinson's disease	3.25e-05	0.0039	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—ADORA2A—Parkinson's disease	3.23e-05	0.00387	CbGpPWpGaD
Nicergoline—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	3.18e-05	0.00381	CbGpPWpGaD
Nicergoline—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	3.13e-05	0.00375	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	3.11e-05	0.00373	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	3.11e-05	0.00373	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—GRK5—Parkinson's disease	2.97e-05	0.00356	CbGpPWpGaD
Nicergoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	2.94e-05	0.00353	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—HTR1A—Parkinson's disease	2.8e-05	0.00336	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—TAC1—Parkinson's disease	2.76e-05	0.00331	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—DRD1—Parkinson's disease	2.71e-05	0.00324	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—GRK5—Parkinson's disease	2.7e-05	0.00323	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—GRM4—Parkinson's disease	2.66e-05	0.00319	CbGpPWpGaD
Nicergoline—CYP2D6—Biological oxidations—COMT—Parkinson's disease	2.63e-05	0.00315	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—DRD3—Parkinson's disease	2.62e-05	0.00314	CbGpPWpGaD
Nicergoline—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	2.62e-05	0.00314	CbGpPWpGaD
Nicergoline—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	2.61e-05	0.00313	CbGpPWpGaD
Nicergoline—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	2.6e-05	0.00311	CbGpPWpGaD
Nicergoline—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	2.58e-05	0.0031	CbGpPWpGaD
Nicergoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	2.54e-05	0.00305	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—VPS35—Parkinson's disease	2.54e-05	0.00304	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—PENK—Parkinson's disease	2.52e-05	0.00302	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	2.49e-05	0.00298	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—GRM4—Parkinson's disease	2.42e-05	0.0029	CbGpPWpGaD
Nicergoline—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	2.41e-05	0.00288	CbGpPWpGaD
Nicergoline—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	2.37e-05	0.00284	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—HTR7—Parkinson's disease	2.37e-05	0.00284	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—DRD2—Parkinson's disease	2.37e-05	0.00284	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—PDYN—Parkinson's disease	2.31e-05	0.00277	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—PENK—Parkinson's disease	2.29e-05	0.00275	CbGpPWpGaD
Nicergoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	2.18e-05	0.00261	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—GRM5—Parkinson's disease	2.15e-05	0.00257	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—DGKQ—Parkinson's disease	2.1e-05	0.00252	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—GPR37—Parkinson's disease	2.1e-05	0.00252	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—PDYN—Parkinson's disease	2.1e-05	0.00251	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—GRM5—Parkinson's disease	1.95e-05	0.00233	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—PPP1R1B—Parkinson's disease	1.92e-05	0.0023	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—EDN1—Parkinson's disease	1.9e-05	0.00227	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—ADORA2A—Parkinson's disease	1.82e-05	0.00219	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—ND3—Parkinson's disease	1.71e-05	0.00204	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—MCCC1—Parkinson's disease	1.71e-05	0.00204	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—RIT2—Parkinson's disease	1.68e-05	0.00201	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR ligand binding—HTR2A—Parkinson's disease	1.66e-05	0.00199	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—ADORA2A—Parkinson's disease	1.66e-05	0.00198	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—OMD—Parkinson's disease	1.6e-05	0.00192	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—TALDO1—Parkinson's disease	1.6e-05	0.00192	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—GRK5—Parkinson's disease	1.59e-05	0.00191	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—HTR1A—Parkinson's disease	1.58e-05	0.0019	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—TAC1—Parkinson's disease	1.56e-05	0.00187	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—DRD1—Parkinson's disease	1.53e-05	0.00183	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	1.52e-05	0.00182	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—DRD3—Parkinson's disease	1.48e-05	0.00177	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—GCH1—Parkinson's disease	1.45e-05	0.00174	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—HTR1A—Parkinson's disease	1.44e-05	0.00172	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—GRM4—Parkinson's disease	1.43e-05	0.00171	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—TAC1—Parkinson's disease	1.42e-05	0.0017	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—DRD1—Parkinson's disease	1.39e-05	0.00166	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	1.38e-05	0.00166	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—MAG—Parkinson's disease	1.35e-05	0.00162	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—PENK—Parkinson's disease	1.35e-05	0.00162	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—DRD3—Parkinson's disease	1.34e-05	0.00161	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—HTR7—Parkinson's disease	1.34e-05	0.0016	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—DRD2—Parkinson's disease	1.34e-05	0.0016	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—GBA—Parkinson's disease	1.29e-05	0.00155	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—DBH—Parkinson's disease	1.29e-05	0.00155	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—FBP1—Parkinson's disease	1.29e-05	0.00155	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—ADRBK1—Parkinson's disease	1.26e-05	0.0015	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—PDYN—Parkinson's disease	1.24e-05	0.00148	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—HTR7—Parkinson's disease	1.22e-05	0.00146	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—DRD2—Parkinson's disease	1.22e-05	0.00146	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—GFAP—Parkinson's disease	1.16e-05	0.00139	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—GRM5—Parkinson's disease	1.15e-05	0.00138	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—EDN1—Parkinson's disease	1.07e-05	0.00128	CbGpPWpGaD
Nicergoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	1.02e-05	0.00122	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—FGF20—Parkinson's disease	1.01e-05	0.00121	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—ADORA2A—Parkinson's disease	9.79e-06	0.00117	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—EDN1—Parkinson's disease	9.74e-06	0.00117	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—DDC—Parkinson's disease	9.49e-06	0.00114	CbGpPWpGaD
Nicergoline—ADRA1A—GPCR downstream signaling—HTR2A—Parkinson's disease	9.38e-06	0.00112	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—INSR—Parkinson's disease	9.03e-06	0.00108	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—GSTA4—Parkinson's disease	8.97e-06	0.00107	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—FGB—Parkinson's disease	8.54e-06	0.00102	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—HTR2A—Parkinson's disease	8.52e-06	0.00102	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—HTR1A—Parkinson's disease	8.49e-06	0.00102	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—TAC1—Parkinson's disease	8.36e-06	0.001	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—DRD1—Parkinson's disease	8.2e-06	0.000983	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	8.07e-06	0.000967	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—MAOB—Parkinson's disease	7.99e-06	0.000957	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—DRD3—Parkinson's disease	7.94e-06	0.000952	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	7.42e-06	0.000889	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	7.18e-06	0.000861	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	7.18e-06	0.000861	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	6.02e-06	0.000721	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—CTGF—Parkinson's disease	5.83e-06	0.000698	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	5.82e-06	0.000697	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	5.75e-06	0.000689	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	5.43e-06	0.000651	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—NQO1—Parkinson's disease	5.37e-06	0.000643	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—TH—Parkinson's disease	5.29e-06	0.000634	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	5.29e-06	0.000633	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—CYCS—Parkinson's disease	5.08e-06	0.000609	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	5.03e-06	0.000603	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	4.68e-06	0.00056	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—COMT—Parkinson's disease	4.5e-06	0.000539	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—GSTP1—Parkinson's disease	4.48e-06	0.000537	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—MAOA—Parkinson's disease	4.47e-06	0.000535	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—HMOX1—Parkinson's disease	4.42e-06	0.000529	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—ABCB1—Parkinson's disease	4.24e-06	0.000508	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—GSTM1—Parkinson's disease	4.12e-06	0.000493	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—INS—Parkinson's disease	4e-06	0.000479	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—GPX1—Parkinson's disease	3.94e-06	0.000472	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—MTHFR—Parkinson's disease	3.64e-06	0.000436	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—APOE—Parkinson's disease	3.39e-06	0.000406	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	2.98e-06	0.000356	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	2.96e-06	0.000354	CbGpPWpGaD
Nicergoline—CYP2D6—Metabolism—INS—Parkinson's disease	2.89e-06	0.000347	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	2.73e-06	0.000328	CbGpPWpGaD
Nicergoline—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	1.75e-06	0.000209	CbGpPWpGaD
